These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1330643

  • 1. Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan.
    Miller KJ, King A, Demchyshyn L, Niznik H, Teitler M.
    Eur J Pharmacol; 1992 Sep 01; 227(1):99-102. PubMed ID: 1330643
    [Abstract] [Full Text] [Related]

  • 2. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
    Perren MJ, Feniuk W, Humphrey PP.
    Br J Pharmacol; 1991 Jan 01; 102(1):191-7. PubMed ID: 1675143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM, Schechter LE, Adham N, Kucharewicz SA, Weinshank RL, Branchek TA.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan 01; 354(3):226-36. PubMed ID: 8878051
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors.
    Pauwels PJ, Wurch T, Palmier C, Colpaert FC.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul 01; 354(2):136-44. PubMed ID: 8857590
    [Abstract] [Full Text] [Related]

  • 7. Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.
    Sumner MJ, Feniuk W, McCormick JD, Humphrey PP.
    Br J Pharmacol; 1992 Mar 01; 105(3):603-8. PubMed ID: 1320980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.
    Villalón CM, Ramírez-San Juan E, Castillo C, Castillo E, López-Muñoz FJ, Terrón JA.
    Br J Pharmacol; 1995 Nov 01; 116(6):2778-84. PubMed ID: 8591004
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA, Elands J, Johnson MP, Linnik MD, Hamel E, Moskowitz MA, Lee WS, McCarty DR, Hibert M, Baron BM.
    Eur J Pharmacol; 1997 Oct 08; 336(2-3):127-36. PubMed ID: 9384224
    [Abstract] [Full Text] [Related]

  • 14. Differentiation between partial and silent 5-HT1D beta receptor antagonists using rat C6-glial and Chinese hamster ovary cell lines permanently transfected with a cloned human 5-HT1D beta receptor gene.
    Pauwels PJ, Colpaert FC.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1651-8. PubMed ID: 7503768
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
    Adham N, Kao HT, Schecter LE, Bard J, Olsen M, Urquhart D, Durkin M, Hartig PR, Weinshank RL, Branchek TA.
    Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):408-12. PubMed ID: 8380639
    [Abstract] [Full Text] [Related]

  • 17. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR, Robertson AD, MacLennan SJ, Prentice DJ, Barrett VJ, Buckingham J, Honey AC, Giles H, Moncada S.
    Br J Pharmacol; 1997 May 15; 121(2):157-64. PubMed ID: 9154322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I, Case B, Olivier A, Hamel E.
    Br J Pharmacol; 2000 Feb 15; 129(3):501-8. PubMed ID: 10711348
    [Abstract] [Full Text] [Related]

  • 20. Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery.
    MacLean MR, Clayton RA, Templeton AG, Morecroft I.
    Br J Pharmacol; 1996 Sep 15; 119(2):277-82. PubMed ID: 8886409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.